Ready to Improve Your Biomarker Intelligence?

TALK TO A BIOMARKER STRATEGIST

Chart of the Week: Alzheimer’s Biomarker and Trial Landscape

by

This week’s CotW includes the landscape of biomarkers and clinical trials for Alzheimer’s disease.  There is significant clustering around two biomarkers, but many interesting emerging biomarkers in clinical trials.
Gray: Disease
Blue: Biomarkers
Purple: Clinical Trials
Yellow: FDA Cleared and Approved Tests

AlzGraph.png

For a larger SVG version click here.

Share this Image On Your Site

<p><strong>Please include attribution to amplion.com with this graphic.</strong><br /><br /><a href=’http://www.amplion.com/biomarker-trends/chart-of-the-week-alzheimers-biomarker-and-trial-landscape’><img src=’https://www.amplion.com/wp-content/uploads/2016/05/AlzGraph.png’ alt=’Alzheimers Biomarker and Trial Landscape’ width=’540px’ border=’0′ /></a></p>

For a refresher on Amplion and BiomarkerBase:

REQUEST DEMO